drugset / Trial / NCT00676156
A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple Sclerosis
Phase 1
Completed
40 enrolled
Oregon Health and Science University
National Center for Complementary and Integrative Health (NCCIH) · collab
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to learn about an investigational drug known as oral lipoic acid (LA) that may help treat multiple sclerosis. This study will measure how a person's body absorbs and breaks down the drug (pharmacokinetics) and will compare four different forms of the drug from four different manufacturers as well as LA in conjunction with fish oil.
Timeline
- Start
- 2005-12
- Primary completion
- 2008-02
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fish oil | Other / unclassified | — | — |
| Comparator | alpha-lipoic acid | Small molecule | 1200 mg | Oral |